Intelligent Bio Solutions Inc.

NASDAQ:INBS

$1.64 USD

-$0.01 (-0.61%)

Volume
53.74K
Average Volume
203.38K
Market Capitalization
$7.19M
P/E Ratio
-0.25
Dividend Yield
0.00%
Price Target
$
Year High
$11.70
Year Low
$1.00
Payout Ratio
$0.00
Current Ratio
$1.14

Industry, Sector & symbol

Stock Exchange NASDAQ Capital Market
CEO Mr. Harry Simeonidis
Industry Medical - Diagnostics & Research
Sector Healthcare
Current Symbol INBS
CUSIP None
CIK 0001725430
Web https://gbs.inc
Phone 646 828 8258
Currency USD
Employees 50
Country US

Liquidity

Debt-to-Equity Ratio 0.08
Payout Ratio 0.00
Current Ratio 1.14
Quick Ratio 1.01
Cash Ratio 0.70

Sales & Book Value

Annual Sales $3.11M
Price / Sales 2.26
Cash Flow -6.85
Price / Cash Flow -0.66
Price / Book 0.43

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-6.38
Trailing P/E Ratio -0.25
PEG Ratio -0.02
P/E Growth -0.02
Net Income $-10.16M
Net Margin -326.63%
Pretax Margin -327.61%
Return on Equity -144.39%
Return on Assets -88.80%

Financials Score

AltmanZ Score -8.34
Piotroski Score 4.00
Working Capital 800.11K
Total Assets 11.73M
Ebit -10.39M
Market Cap 7.24M
Total Liabilities 5.78M

Poll Results

About Intelligent Bio Solutions Inc. (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. ... is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET

2024-12-04 08:30:00

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it will host a virtual fireside chat with Harry Simeonidis, President & CEO and Spiro Sakiris, CFO at 4:30 p.m. ET on December 11, 2024.

Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference

2024-11-21 08:30:00

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets' 20th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL.

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

2024-11-18 11:55:25

Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for FDA submission of its Intelligent Fingerprinting Drug Screening System.

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

2024-10-31 08:30:00

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a strategic partnership with B2i Digital to launch an investor-focused marketing campaign. B2i Digital will employ advanced digital marketing strategies to raise awareness of INBS' patented drug screening technology, which offers a fast, non-invasive, and efficient alternative to traditional drug tests.

Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results

2024-10-29 08:30:00

Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary driver Expanded distribution network in Saudi Arabia NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary unaudited revenue results for the fiscal first quarter ended September 30, 2024. The Company expects unaudited revenue of approximately $0.87 million for the three months ended September 30, 2024, representing an increase of 10% year-on-year and 20% quarter-on-quarter.

Frequently Asked Questions

What is the current Intelligent Bio Solutions Inc. (INBS) stock price?

Intelligent Bio Solutions Inc.(NASDAQ:INBS) stock price is $1.64 in the last trading session. During the trading session, INBS stock reached the peak price of $11.7 while $1.0 was the lowest point it dropped to. The percentage change in INBS stock occurred in the recent session was --0.61% while the dollar amount for the price change in INBS stock was -$-0.01.

INBS's industry and sector of operation?

The NASDAQ listed INBS is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of INBS?

Mr. Harry Simeonidis | President & Chief Executive Officer
Mr. Alex Arzeno | Vice President of Investor Relations
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer
|
|

How many employees does INBS have?

Number of INBS employees currently stands at 50. INBS operates from 142 West 57th Street, New York, NY 10019, US.

Link for INBS official website?

Official Website of INBS is: https://gbs.inc

How do I contact INBS?

INBS could be contacted at phone #646 828 8258 and can also be accessed through its website. INBS operates from 142 West 57th Street, New York, NY 10019, US.

How many shares of INBS are traded daily?

The average number of INBS shares traded daily for last 3 months was 203.38K.

What is the market cap of INBS currently?

The market value of INBS currently stands at $7.19M with its latest stock price at $1.64